POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1l8r DACHSHUND
(Homo
sapiens)		6 / 12LEU A 219
VAL A 229
LEU A 208
ILE A 267
LEU A 233
LYS A 232
None
1.30A17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1m7t CHIMERA OF HUMAN AND
E. COLI THIOREDOXIN
(Escherichia
coli;
Homo
sapiens)		5 / 12LEU A  78
VAL A  25
ILE A   5
LEU A  55
VAL A  65
None
1.13A22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1u6g TIP120 PROTEIN
(Homo
sapiens)		5 / 12VAL C  79
LEU C  91
ILE C  87
LYS C  80
VAL C  69
None
1.13A8.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1zsq MYOTUBULARIN-RELATED
PROTEIN 2
(Homo
sapiens)		6 / 12LEU A 433
VAL A 487
LEU A 540
ILE A 508
LEU A 505
VAL A 449
None
1.44A14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2dh3 4F2 CELL-SURFACE
ANTIGEN HEAVY CHAIN
(Homo
sapiens)		5 / 12LEU A 153
VAL A 155
LEU A 129
ILE A 126
LEU A 192
None
1.13A18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2ro1 TRANSCRIPTION
INTERMEDIARY FACTOR
1-BETA
(Homo
sapiens)		5 / 12LEU A 740
ILE A 743
LEU A 788
PHE A 792
MET A 796
None
1.13A24.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens)		5 / 12LEU A  48
VAL A 136
VAL A 134
PHE A  89
MET A  87
PCF  A1179 (-4.1A)
None
PCF  A1179 ( 4.7A)
PCF  A1179 ( 3.8A)
PCF  A1179 (-3.6A)
1.11A18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens)		5 / 12LEU A  48
VAL A 136
VAL A 134
PHE A  89
MET A  87
PCF  A1213 (-4.3A)
None
PCF  A1213 ( 4.6A)
PCF  A1213 (-4.1A)
PCF  A1213 ( 3.8A)
1.13A17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3fbk REGULATOR OF
G-PROTEIN SIGNALING
3
(Homo
sapiens)		5 / 12LEU A  50
VAL A 116
LEU A 141
PHE A 136
MET A 134
None
1.07A24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3gcw PROPROTEIN
CONVERTASE
SUBTILISIN/KEXIN
TYPE 9
(Homo
sapiens)		5 / 12LEU A 230
VAL A 233
LEU A 415
VAL A 312
VAL A 310
None
0.95A14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3nbh RECQ-MEDIATED GENOME
INSTABILITY PROTEIN
2
(Homo
sapiens)		5 / 12LEU B  30
LEU B  86
VAL B 104
VAL B 102
MET B  60
None
1.00A22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3nmz APC VARIANT PROTEIN
(Homo
sapiens)		5 / 12LEU A 563
VAL A 566
LEU A 479
VAL A 547
VAL A 543
None
1.10A17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3pg6 E3 UBIQUITIN-PROTEIN
LIGASE DTX3L
(Homo
sapiens)		5 / 12LEU A 727
VAL A 673
ILE A 635
LEU A 677
GLU A 733
None
1.12A18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		1c07 PROTEIN (EPIDERMAL
GROWTH FACTOR
RECEPTOR PATHWAY
SUBSTRATE 15)
(Homo
sapiens)		3 / 3LYS A  19
ILE A  23
ILE A  43
None
0.68A18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		1tff UBIQUITIN
THIOLESTERASE
PROTEIN OTUB2
(Homo
sapiens)		3 / 3LYS A  44
ILE A  42
ILE A  15
None
0.69A19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		2a98 INOSITOL
1,4,5-TRISPHOSPHATE
3-KINASE C
(Homo
sapiens)		3 / 3LYS A 559
ILE A 557
ILE A 554
None
0.70A22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		2aw5 NADP-DEPENDENT MALIC
ENZYME
(Homo
sapiens)		3 / 3LYS A 173
ILE A 169
ILE A 156
None
0.60A14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		2dgp BRUNO-LIKE 4, RNA
BINDING PROTEIN
(Homo
sapiens)		3 / 3LYS A 119
ILE A 128
ILE A  58
None
0.67A23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		2ld4 ANAMORSIN
(Homo
sapiens)		3 / 3LYS A  56
ILE A  86
ILE A  63
None
0.66A21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		2zkm 1-PHOSPHATIDYLINOSIT
OL-4,5-BISPHOSPHATE
PHOSPHODIESTERASE
BETA-2
(Homo
sapiens)		3 / 3LYS X 461
ILE X 404
ILE X 323
None
0.58A12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		3be8 NEUROLIGIN-4,
X-LINKED
(Homo
sapiens)		3 / 3LYS A 166
ILE A 197
ILE A 151
None
0.64A15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		3bwm CATECHOL
O-METHYLTRANSFERASE
(Homo
sapiens)		3 / 3LYS A   5
ILE A   9
ILE A  29
None
0.57A23.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		3dwb ENDOTHELIN-CONVERTIN
G ENZYME 1
(Homo
sapiens)		3 / 3LYS A 496
ILE A 500
ILE A 576
None
0.69A13.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		3jar MICROTUBULE-ASSOCIAT
ED PROTEIN RP/EB
FAMILY MEMBER 3
(Homo
sapiens)		3 / 3LYS N 112
ILE N 108
ILE N  35
None
0.64A21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		3lfl GLUTATHIONE
S-TRANSFERASE
OMEGA-1
(Homo
sapiens)		3 / 3LYS A  45
ILE A  47
ILE A  24
None
0.68A24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		3q19 GLUTATHIONE
S-TRANSFERASE
OMEGA-2
(Homo
sapiens)		3 / 3LYS A  45
ILE A  47
ILE A  24
None
0.70A20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		4c41 CORTICOSTEROID-BINDI
NG GLOBULIN
(Homo
sapiens)		3 / 3LYS A  39
ILE A  41
ILE A  43
None
0.56A18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2dgx KIAA0430 PROTEIN
(Homo
sapiens)		5 / 12VAL A 602
LEU A 598
ILE A 562
ILE A 627
ILE A 622
None
0.79A17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2ocp DEOXYGUANOSINE
KINASE
(Homo
sapiens)		5 / 12LEU A 248
ILE A 190
LEU A 192
ILE A  43
ILE A 139
None
1.01A24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3dtc MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 9
(Homo
sapiens)		5 / 12ILE A 249
LEU A 338
ILE A 274
ILE A 292
PHE A 396
None
1.04A21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3q6z POLY [ADP-RIBOSE]
POLYMERASE 14
(Homo
sapiens)		5 / 12LEU A 804
LEU A 959
ILE A 957
LEU A 954
ILE A 916
None
1.06A21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3zus BOTULINUM NEUROTOXIN
TYPE A,
SYNAPTOSOMAL-ASSOCIA
TED PROTEIN 23
(Clostridium
botulinum;
Homo
sapiens)		5 / 12LEU A 225
LEU A 107
ILE A 111
GLU A 148
PHE A   3
None
1.04A10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4d86 POLY [ADP-RIBOSE]
POLYMERASE 14
(Homo
sapiens)		5 / 12LEU A 804
LEU A 959
ILE A 957
LEU A 954
ILE A 916
None
1.02A17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4qj4 1-PHOSPHATIDYLINOSIT
OL 4,5-BISPHOSPHATE
PHOSPHODIESTERASE
BETA-3
(Homo
sapiens)		5 / 12VAL B 672
LEU B 674
GLU B 622
VAL B 689
PHE B 690
None
1.04A12.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4r0b GLYCODELIN
(Homo
sapiens)		7 / 12VAL A  41
LEU A  46
LEU A  54
ILE A  56
LEU A  58
GLU A  62
ILE A  84
None
0.71A41.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4r0b GLYCODELIN
(Homo
sapiens)		5 / 12VAL A  41
LEU A  54
LEU A  58
GLU A  62
LYS A  69
None
0.78A41.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4uy9 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 9
(Homo
sapiens)		5 / 12ILE A 249
LEU A 338
ILE A 274
ILE A 292
PHE A 396
None
0.86A21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		5c1b TRANSITIONAL
ENDOPLASMIC
RETICULUM ATPASE
(Homo
sapiens)		5 / 12LEU A 306
ILE A 303
GLU A 292
ILE A 269
ILE A 274
None
0.94A12.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		5oko PHOSPHATIDYLINOSITOL
3,4,5-TRISPHOSPHATE
5-PHOSPHATASE 2
(Homo
sapiens)		5 / 12LEU A 631
LEU A 612
ILE A 619
LEU A 620
ILE A 616
None
1.03A17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		5yq5 OSTEOMODULIN
(Homo
sapiens)		5 / 12LEU A 146
ILE A 120
LEU A 117
ILE A  86
VAL A 106
None
0.70Aundetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		5yq5 OSTEOMODULIN
(Homo
sapiens)		5 / 12LEU A 146
LEU A 148
LEU A  96
ILE A 103
VAL A 106
None
1.01Aundetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0R_A_PX9A201_0
(BETA-LACTOGLOBULIN)		6d6q EXOSOME RNA HELICASE
MTR4
(Homo
sapiens)		5 / 12VAL M 441
LEU M1040
ILE M 462
LEU M 463
ILE M1034
None
1.07Aundetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1a1z FADD PROTEIN
(Homo
sapiens)		5 / 12VAL A  39
LEU A  63
LEU A  67
VAL A  11
LEU A   8
None
0.95A21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1bhg BETA-GLUCURONIDASE
(Homo
sapiens)		5 / 12LEU A 166
ILE A 168
ILE A 123
VAL A 119
LEU A 156
None
0.91A14.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		1ugk SYNAPTOTAGMIN IV
(Homo
sapiens)		6 / 12LEU A 115
LEU A 120
ILE A 118
VAL A  26
LEU A  92
PHE A  13
None
1.38A18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2dlu INAD-LIKE PROTEIN
(Homo
sapiens)		5 / 12VAL A  19
LEU A  83
ILE A  45
VAL A  42
VAL A  40
None
0.97A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2o2v DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 5
(Homo
sapiens)		5 / 12LEU A 102
ILE A 104
ILE A  48
VAL A  44
LEU A  82
None
0.78A20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2ro1 TRANSCRIPTION
INTERMEDIARY FACTOR
1-BETA
(Homo
sapiens)		6 / 12LEU A 740
ILE A 743
VAL A 707
LEU A 788
PHE A 792
MET A 796
None
1.25A23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		2z0u WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)		6 / 12LEU A  29
ILE A  27
ILE A  61
VAL A  63
VAL A  65
LEU A 130
None
0.87A21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3ll8 SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2B
CATALYTIC SUBUNIT
ALPHA ISOFORM
(Homo
sapiens)		6 / 12LEU A 209
LEU A  78
ILE A 212
ILE A 230
VAL A 198
LEU A 274
None
1.34A18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		3p11 RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3
(Homo
sapiens)		5 / 12LEU A  58
LEU A  80
ILE A  61
VAL A  68
VAL A  70
None
0.95A14.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4h87 KANADAPTIN
(Homo
sapiens)		5 / 12LEU A 169
VAL A 259
VAL A 257
LEU A 213
PHE A 231
None
0.97A16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0S_A_PX9A201_0
(BETA-LACTOGLOBULIN)		4leo RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3
(Homo
sapiens)		5 / 12LEU C  58
LEU C  80
ILE C  61
VAL C  68
VAL C  70
None
0.93A13.09